Respiratory depression following medications for opioid use disorder (MOUD)-approved buprenorphine product oral exposures; National Poison Database System 2003

Respiratory depression following medications for opioid use disorder (MOUD)-approved buprenorphine product oral exposures; National Poison Database System 2003–2019

Published:2020-09-07 Issue:4 Volume:59 Page:303-312
ISSN:1556-3650
Container-title:Clinical Toxicology
language:en
Short-container-title:Clinical Toxicology

Author:

Darracq Michael A.¹,Thornton Stephen L.²

Affiliation:

1. Department of Emergency Medicine, Division of Medical Toxicology, Fresno Medical Education Program, University of California, San Francisco (UCSF), Fresno, CA, USA;

2. Department of Emergency Medicine, Kansas Poison Control System, University of Kansas Health System, Kansas City, KS, USA

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15563650.2020.1814318

Reference25 articles.

1. HHS: what is the U.S. opioid epidemic. Washington (DC): US Department of Health and Human Services; [cited 2019 Sep 4]; 2019. Available from: https://www.hhs.gov/opioids/about-the-epidemic/index.html

2. HHS: secretary price announces HHS strategy for fighting opioid crisis. Washington (DC): US Department of Health and Human Services; [cited 2017 Apr 19]; 2017. Available from: https://www.hhs.gov/about/leadership/secretary/speeches/2017-speeches/secretary-price-announces-hhs-strategy-for-fighting-opioid-crisis/index.html

3. SAMHSA: medication assisted treatment (MAT). Washington (DC): Substance Abuse and Mental Health Services Administration; [cited 2020 Jul 9]; 2020. Available from: https://www.samhsa.gov/medication-assisted-treatment

4. SAMHSA: buprenorphine. Washington (DC). Substance Abuse and Mental Health Services Administration; [cited 2020 May 4]; 2020. Available from: https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine

5. SAMHSA: statues, regulations, and guidelines. Washington (DC): Substance Abuse and Mental Health Services Administration; [cited 2020 Jul 22]; 2020. Available from: https://www.samhsa.gov/medication-assisted-treatment/statutes-regulations-guidelines

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic;BMJ Open;2023-11

2. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study;Harm Reduction Journal;2023-10-17

3. Reversal of increases in methadone distribution for opioid use disorder in the US during the COVID-19 pandemic;2022-03-12

4. Buprenorphine: a treatment and cause of opioid-induced respiratory depression;British Journal of Anaesthesia;2022-03

5. Drugs of abuse;Side Effects of Drugs Annual;2022